Hung Randy King Kuen resigned as China Shineway Pharmaceutical Group Ltd.'s independent nonexecutive director to focus on his personal affairs.
China Shineway is searching for Kuen's replacement for continued listing on the Hong Kong Stock Exchange.
China Shineway Pharmaceutical nonexecutive director resigns
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective
China Shineway Pharmaceutical nonexecutive director resigns
- Author Angelee Tabios
- Theme Healthcare & Pharmaceuticals
- Author
- Angelee Tabios
- Theme
- Healthcare & Pharmaceuticals